Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey.
about
Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients.Brentuximab vedotin in pretreated Hodgkin lymphoma patients: a systematic review and meta-analysis.Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma.Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients.Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma.Brentuximab vedotin: clinical updates and practical guidance.Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countries.Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.Bendamustine as a bridge to allogeneic transplant in relapsed/refractory Hodgkin lymphoma patients who failed salvage brentuximab vedotin postautologous peripheral blood stem cell transplantation.
P2860
Q36371623-759CDF58-A75E-4203-B145-24D6FA42166BQ38812806-17FFF94D-02F1-40A3-A4BF-58B789EB4439Q38951604-CA9FF3CA-301E-47D7-B96C-CE844BF2B284Q39132041-E6DBF343-5259-413D-9A79-5A901A179C96Q39530535-884E213D-4E05-4E10-90FC-21A436371C05Q47130656-3D0259CC-398B-4643-AA83-12F343DA14FFQ49282959-50A19513-5797-4E89-8199-35C2BF54A284Q50044569-4F1FCB50-2D3A-452F-AD75-E29BCCA9899CQ50271165-489233DD-0492-487D-B350-998B46C6C693Q52779365-9F557673-6043-43F2-AF2B-95E722BCA996
P2860
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey.
@ast
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey.
@en
type
label
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey.
@ast
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey.
@en
prefLabel
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey.
@ast
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey.
@en
P2093
P2860
P50
P1433
P1476
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
@en
P2093
A Salihoglu
I Karadogan
N Karadurmus
P2860
P304
P356
10.1007/S00277-014-2215-9
P577
2014-09-18T00:00:00Z